CONTROVERSIAL TOPICS :
- Ezetimibe: USEFUL or not?
- STATINS: Increase Incidence of Diabetes!
- Combination Therapy (STATINS + FIBRATES): Increase Incidence of Myalagia (ATEF ELBAHRY)
- CRP-Hs Is It Matter?
- HDL-RISING Why We Pass Over?
HOT TOPICS:
- EMERGING CV GENETIC MARKERS: Assessing Their Role In Clinical Practice.
- Mipomersen, a new agent that reduces Lp (a) as well as LDL.
- Genome-Wide Association of Statin-Induced Myopathy (SEARCH TRIAL).
- Glycemic Control Slows Rates of Carotid Artery Disease Progression.
- Niacin has Vascular Benefits Beyond Lipid Lowering.
PREDICTION OF EARLY CAD:
- HDL-PROTEOMIC Signature Could AID CAD Diagnosis
- NON-HDL Strongly Associated With Coronary Calcification
- LDL-HDL C Ratio is a Marker of Early Atherosclerosis
- ABO B & A-I Levels Predict Ischemic Stroke Risk in Patients with CHD
- Endothelial Dysfunction Marker Effect Varies by Statin Dose (ADMA-ASYMMETRIC DIMETHYLARGININ)
- Accuracy Non-Fasting vs Fasting Lipid Measures for CVD Prediction
CLINICAL TRIALS & TRIBULATIONS:
- ACCORD
- ARBITER -6 HALTS
- BARI 2D
- RECORD
